Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altrock

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|February 17, 2023
Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Cancer Research|October 4, 2023
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy CyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Bulletin of Mathematical Biology|July 11, 2020
High School Internship Program in Integrated Mathematical Oncology (HIP IMO): Five-Year Experience at Moffitt Cancer CenterHeiko Enderling, Philipp M Altrock, Noemi Andor, et al.
Nature Ecology & Evolution|January 19, 2021
Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populationsDaria Miroshnychenko, Etienne Baratchart, Meghan C Ferrall-Fairbanks, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediatorsBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2021
The harsh microenvironment in early breast cancer selects for a Warburg phenotypeMehdi Damaghi, Jeffrey West, Mark Robertson-Tessi, et al.
Research Square|May 2, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancersBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
The Lancet Regional Health. Europe|October 29, 2025
Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysisDavid Baden, Nadine Wolgast, Philipp M Altrock, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|February 17, 2023
Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Cancer Research|October 4, 2023
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy CyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Bulletin of Mathematical Biology|July 11, 2020
High School Internship Program in Integrated Mathematical Oncology (HIP IMO): Five-Year Experience at Moffitt Cancer CenterHeiko Enderling, Philipp M Altrock, Noemi Andor, et al.
Nature Ecology & Evolution|January 19, 2021
Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populationsDaria Miroshnychenko, Etienne Baratchart, Meghan C Ferrall-Fairbanks, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediatorsBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2021
The harsh microenvironment in early breast cancer selects for a Warburg phenotypeMehdi Damaghi, Jeffrey West, Mark Robertson-Tessi, et al.
Research Square|May 2, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancersBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
The Lancet Regional Health. Europe|October 29, 2025
Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysisDavid Baden, Nadine Wolgast, Philipp M Altrock, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Pageof 6